Abstract
Post-COVID aseptic necrosis of the femoral head and dysplastic coxarthrosis are emerging conditions observed in patients recovering from COVID-19. Both disorders lead to progressive joint degeneration and severe pain, significantly affecting patients' mobility and quality of life. Aseptic necrosis of the femoral head, often seen in COVID-19 patients with a history of steroid use, can lead to irreversible damage to the hip joint if not diagnosed and treated early. Meanwhile, dysplastic coxarthrosis is a result of abnormal development of the hip joint, which may be exacerbated by the systemic effects of COVID-19 infection, including inflammatory responses and vascular compromise. This article aims to explore the pathophysiology, diagnostic approaches, and treatment options for these conditions in post-COVID patients, emphasizing early intervention and management strategies to prevent long-term disability. We also discuss the role of imaging techniques in early diagnosis, the potential for pharmacological and surgical treatments, and the importance of rehabilitation. Addressing these conditions promptly is crucial to reduce the burden of hip joint complications in the post-COVID population.